WINDTREE THERAPEUTICS INC /DE/ Defined Contribution Plan, Cost
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Defined Contribution Plan, Cost of $500.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2016-03-29
- WINDTREE THERAPEUTICS INC /DE/ defined contribution plan, cost for fiscal 2015 was $500.00K, a 50.00% decline from fiscal 2014.
- WINDTREE THERAPEUTICS INC /DE/ defined contribution plan, cost for fiscal 2014 was $1.00M, a 0.00% change from fiscal 2013.
- WINDTREE THERAPEUTICS INC /DE/ defined contribution plan, cost for fiscal 2013 was $1.00M, a 25.00% increase from fiscal 2012.
- WINDTREE THERAPEUTICS INC /DE/ defined contribution plan, cost for fiscal 2012 was $800.00K, a 60.00% increase from fiscal 2011.
| Period end | Defined Contribution Plan, Cost 12 month |
|---|---|
| 2015-12-31 | $500.00K 10-K · filed 2016-03-29 |
| 2014-12-31 | $1.00M 10-K · filed 2016-03-29 |
| 2013-12-31 | $1.00M 10-K · filed 2015-03-16 |
| 2012-12-31 | $800.00K 10-K · filed 2015-03-16 |
| 2011-12-31 | $500.00K 10-K · filed 2014-03-17 |
| 2010-12-31 | $200.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |